DPC study of endoscopic and surgical resection for rectal neuroendocrine tumors

Short-term Outcomes of Endoscopic and Surgical Resection for Rectal Neuroendocrine Tumors: A DPC Database Study - RECT-NET DPC study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060565

Enrollment

500

Registered

2026-02-15

Start date

2026-02-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal neuroendocrine tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with rectal neuroendocrine tumors registered in the DPC database who underwent endoscopic or surgical resection between January 2012 and December 2023.

Exclusion criteria

Exclusion criteria: - Patients who underwent simultaneous surgery for other diseases - Patients with missing data

Design outcomes

Primary

Measure	Time frame
Periprocedural adverse events common to endoscopic and surgical treatment.	—

Secondary

Measure	Time frame
Treatment-specific adverse events (surgery-related and endoscopy-specific events), additional surgery, total transfusion volume, in-hospital mortality, length of hospital stay, and total medical costs.	—

Countries

Japan

Contacts

Public ContactKenichiro Imai

Shizuoka Cancer Center Division of Endoscopy

ke.imai@scchr.jp055-989-5222

Outcome results